Ocular Surface Changes in Prostaglandin Analogue-Treated Patients

Ocular Surface Changes in Prostaglandin Analogue-Treated Patients

Glaucoma is the second leading cause of blindness globally. Reducing intraocular pressure (IOP) has been acknowledged to be the main therapy for glaucoma. Prostaglandin analogues (PGAs) have become the first-line therapy for patients with glaucoma due to their powerful efficacy for lowering (IOP). H...

Full description

Saved in:
Bibliographic Details
Main Authors: Wencui Shen, Bingqing Huang, Jin Yang
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2019/9798272
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items